Catalog Number 1012463-28 |
Device Problem
Adverse Event Without Identified Device or Use Problem (2993)
|
Patient Problems
Angina (1710); Cardiac Enzyme Elevation (1838); Myocardial Infarction (1969); Perforation (2001); Thrombosis (2100)
|
Event Date 01/11/2016 |
Event Type
Injury
|
Manufacturer Narrative
|
(b)(4).Multiple attempts to open the lad were made with multiple balloon angioplasties and aspiration thrombectomy.Aggressive dilatation caused a class-iii perforation, which was sealed with a 2.8x19 mm covered-stent and post-dilated with a 3.0 noncompliant balloon.Timi-iii flow was restored despite diffuse lad disease.Residual stenosis was 70% and 50% in the dlad and mlad, respectively.After 72 hours, a second-look angiography using a 6f radial approach showed a patent lad, well expanded stent/scaffolds, and diffuse lad disease with dlad dissection and residual stenosis in the proximal lad.Oct of the mlad and dlad showed intramural hematoma.Angiogram of the coronary arteries during the third angiography showed patent lumen with well expanded stents/scaffolds.Oct of the lad, mlad, and dlad was 0, 50, and 40 percent respectively.The patient was kept on gpiib/iiia inhibitors for another 24 hours, with ticagrelor instead of clopidogrel.The scaffold remains in the patient.Investigation is not yet complete.A follow up report will be submitted with all relevant information.The other absorb is being filed under a separate medwatch report.Literature attachment: a case of subacute bioresorbable vascular scaffold thrombosis, what was wrong? the absorb device is currently not commercially available in the u.S; however, it is similar to a device sold in the u.S.
|
|
Event Description
|
The following information was reported through a research article titled: a case of subacute bioresorbable vascular scaffold thrombosis, what was wrong? it was reported that the patient presented to the emergency department complaining of typical angina.Electrocardiography (ecg) showed normal sinus rhythm with non-specific st-t wave changes.Echocardiography returned normal results.Coronary angiography using a 6f right radial approach showed mid (mlad) to distal lad (dlad) lesions with 75% and 70% stenosis, respectively, and diffuse dlad disease reaching the apex.The lesions were pre-dilated with a 2.5x20 mm balloon and stented with an absorb (3.0x28 mm) in the mlad and 2.5x28 mm absorb in the dlad.Post-dilatation with 3.0 and 3.5 non-compliant balloons was performed in the mid and distal scaffolds.Optical coherence tomography (oct) confirmed good apposition of both scaffolds, no residual stenosis in the mlad and diffuse dlad disease.The patient was kept on dual antiplatelet therapy (dapt) consisting of aspirin and clopidogrel.Six days later, the patient presented with continuous mild chest pain and an ecg showed t-wave inversion in the anterolateral leads and had elevated troponin i (8.817 ng/ml).The patient was diagnosed with non-st elevation myocardial infarction.The next day, coronary angiography showed in-scaffold thrombosis with timi-0 flow in the mlad where the 3.0x28mm absorb scaffold was implanted.
|
|
Manufacturer Narrative
|
Internal file number - (b)(4).There was no reported device malfunction and the product was not returned as the scaffold remains in the anatomy.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.The reported patient effects of angina, myocardial infarction, perforation and thrombosis, as listed in the bioresorbable vascular scaffold (bvs) system, absorb, instructions for use are known adverse events associated with the use of a coronary scaffold in native coronary arteries.Based on the case information and related record review, a conclusive cause for the reported patient effects, and the relationship to the product, if any, cannot be determined.There is no indication of a product quality issue with respect to design, manufacture or labeling of the device.
|
|
Event Description
|
Additional information: the reported dissection in the distal left anterior descending artery was treated with balloon dilatation and the hematoma was treated with a 2.5x28mm bioresorbable vascular scaffold.
|
|
Search Alerts/Recalls
|
|